A robust genomic-based prognostic model for the assessment of cancer stemness and survival for patients with hepatocellular carcinoma

Hepatobiliary Pancreat Dis Int. 2024 Feb;23(1):97-102. doi: 10.1016/j.hbpd.2023.09.002. Epub 2023 Sep 4.

Authors

Cheng-Li Du¹, Shen-Yu Wei², Yun-Hao Chen¹, Kang-Jie Chen³

Affiliations

¹ Division of Thoracic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
² Zhejiang University School of Medicine, Hangzhou 310003, China.
³ Division of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. Electronic address: ckj_zyyy@zju.edu.cn.

PMID: 37709605
DOI: 10.1016/j.hbpd.2023.09.002

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Hepatocellular* / pathology
Cell Line, Tumor
Genomics
Humans
Liver Neoplasms* / genetics
Liver Neoplasms* / therapy
Prognosis